Pfizer Inc. (NYSE:PFE)

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer’s Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.

Pfizer Inc. (NYSE:PFE)’s Financial Overview

Pfizer Inc. (NYSE:PFE) surged 0.69% yesterday to close its trading session at $32.14. The company has 1 year Price Target of $37.86. Pfizer Inc. has 52-Week high of $37.39 and 52-Week Low of $28.25. The stock touched its 52-Week High on Aug 1, 2016 and 52-Week Low on Feb 8, 2016. The stock traded with the volume of 38.5 Million shares yesterday. The firm shows the market capitalization of $195.04 Billion.

Pfizer Inc. (NYSE:PFE) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $0.61/share against the analyst consensus estimate of $0.62/share. The difference between the actual and expected EPS is $-0.01 a share with a surprise factor of -1.6%.

The firm is trading with SMA20 of 2.37 Percent, SMA50 of -0.34 Percent and SMA200 of -1.77 percent. Pfizer Inc. has P/S value of 3.66 while its P/B value stands at 3.08. Similarly, the company has Return on Assets of 3.6 percent, Return on Equity of 9.7 percent and Return on Investment of 7.3 Percent. The company shows Gross Margin and Operating Margin of 76.6 percent and 15.1 percent respectively.

Many brokerage firms are involved in issuing their ratings on Pfizer Inc. (NYSE:PFE). On 2-Nov-16 Argus Downgrade Pfizer Inc. Stock  to Hold. Another firm also rated the stock on 13-Oct-16 where Jefferies Downgrade the stock to Hold.

The Stock currently has Analyst’ mean Recommendation of 2.4 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 21 analysts offering 12-month price forecasts for Pfizer have a median target of 38.00, with a high estimate of 53.00 and a low estimate of 33.00. The median estimate represents a +18.23% increase from the last price of 32.14.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Noble Corporation plc (NYSE:NE)

Noble Corporation PLC is an offshore drilling contractor for the oil and gas industry. The company offers services for drilling and work over activities and undertakes refurbishment projects for rigs. It provides services primarily in the U.S. Gulf of Mexico and Alaska, Mexico, Brazil, the North Sea, the Mediterranean, West Africa, the Middle East, India, Malaysia and Australia. Noble Corporation PLC, formerly known as Noble Corp., is based in London, United Kingdom.

Noble Corporation plc (NYSE:NE)’s Financial Outlook

The 33 analysts offering 12-month price forecasts for Noble Corporation PLC have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a -3.54% decrease from the last price of 6.22.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, Noble Corporation plc has a Consensus Recommendation of 3.41. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock gained 16.48% and closed its last trading session at $6.22. The company has the market capitalization of $1.51 Billion. The stock has 52-week high of $13.9 and 52-Week low of $4.45. The firm touched its 52-Week high on Mar 7, 2016 and 52-Week low on Nov 4, 2016. The company has volume of 23.36 Million shares. The company has a total of 243.24 Million shares outstanding.

Noble Corporation plc (NYSE:NE) in the last quarter reported its actual EPS of $-0.23/share where the analyst estimated EPS was $-0.2/share. The difference between the actual and Estimated EPS is $-0.03. This shows a surprise factor of -15 percent.

The company has YTD performance of -39.58 percent. Beta for Noble Corporation plc stands at 2.14 while its ATR (average true range) is 0.39. The company has Weekly Volatility of 5.74%% and Monthly Volatility of 6.20%%.

Noble Corporation plc has distance from 20-day Simple Moving Average (SMA20) of 18.86%, Distance from 50-Day Simple Moving Average of 11.3 percent and Distance from 200-Day Simple Moving Average of -21.16%.

The Company currently has ROA (Return on Assets) of 1.7 percent, Return on Equity (ROE) of 3 Percent and Return on Investment (ROI) of 6.8% with Gross margin of 61.6 percent and Operating & Profit margin of 21.3% and 7.6% respectively.